Robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer.
Summary of "Robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer."
Abstract Neoadjuvant platinum-based chemotherapy (NACT) plus radical hysterectomy and pelvic lymphadenectomy has been demonstrated to be a valid alternative to chemoradiation in patients with advanced cervical cancer. Several publications have reported on the feasibility of robot-assisted laparoscopy in early cervical cancer. Herein is reported the case of a woman with locally advanced cervical cancer that was successfully treated using neoadjuvant chemotherapy followed by total robotic type C1 radical hysterectomy (TRRH) plus pelvic lymphadenectomy. The success of this approach, which is not the standard of care in this disease, suggests that additional studies should be performed in a selected population.
Affiliation
Gynecologic Oncology Unit, National Cancer Institute "Regina Elena" , Rome , Italy.
Journal Details
This article was published in the following journal.
Name: Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy
ISSN: 1365-2931
Pages:
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/22554031
- DOI: http://dx.doi.org/10.3109/13645706.2012.672426
Medical and Biotech [MESH] Definitions
Neoadjuvant Therapy
Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.
Hydroxyl Radical
The univalent radical OH. Hydroxyl radical is a potent oxidizing agent.
Hysterectomy
Excision of the uterus.
Technology, High-cost
Advanced technology that is costly, requires highly skilled personnel, and is unique in its particular application. Includes innovative, specialized medical/surgical procedures as well as advanced diagnostic and therapeutic equipment.
Hysterectomy, Vaginal
Removal of the uterus through the vagina.
PubMed Articles
ABSTRACT: BACKGROUND: Neoadjuvant chemotherapy is the standard care for locally advanced breast cancer. Our study aimed at evaluating the feasibility of breast conversation surgery (BCS) after neoadju...
Please cite this paper as: Koehler C, Gottschalk E, Chiantera V, Marnitz S, Hasenbein K, Schneider A. From laparoscopic assisted radical vaginal hysterectomy to vaginal assisted laparoscopic radical h...
OBJECTIVE: To evaluate the effectiveness of neoadjuvant chemotherapy (NAC) followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for stage IB2-IIB cervical cancer. METHO...
Locally advanced breast cancer (LABC) remains a clinical challenge as the majority of patients with this diagnosis develop distant metastases despite appropriate therapy. We analyzed expression of ste...
BACKGROUND: Cervical cancer (including carcinoma in situ) is the most common malignancy during pregnancy. Neoadjuvant chemotherapy (NACT) with paclitaxel plus cisplatin has been used in patients with...
Clinical Trials
Laparoscopic Approach to Cervical Cancer
The primary objective of this study is to assess disease-free survival at 4.5 years postoperatively amongst patients who undergo a Total Laparoscopic (TLRH) or Total Robotic Radical Hyster...
Study Comparing Conventional vs. Robotic-assisted Laparoscopic Hysterectomy
The purpose of this study is to compare two ways of performing laparoscopic hysterectomy - robotic-assisted vs. conventional laparoscopy.
A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer
To investigate the clinical benefits of neoadjuvant chemotherapy for bulky stage I/II cervical cancer
Carcinoma cervix is a common malignancy in women in developing countries including India. The standard treatment of locally advanced cervical cancer (Stages IB2 to IIIB)is concomitant chem...
A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)
1. This is a phase II study of radiotherapy for patients with locally advanced HCC. 2. Patients whose tumor(s) are not suitable for other local treatment, such as surgery, trans-a...
